Evidence map›Paper›PMID 42098131›Full record

ArticleNature communications2026

Astroglial disinhibition of cortical circuits disrupts cognition via kynurenic acid in mice.

Viktor Beilmann, Johanna Furrer, Sina M Schalbetter, Ron Schaer, Edoardo Tiziani, Kim D Ferrari, Felisa Herrero, Celine Heeb, Alexandra von Faber-Castell, Jacqueline Condrau and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Viktor Beilmann *Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
Johanna Furrer *Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-3090-0013
Sina M SchalbetterInstitute of Veterinary Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
Ron SchaerInstitute of Veterinary Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
Edoardo TizianiDepartment of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.
Kim D FerrariInstitute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-7565-1276
Felisa HerreroInstitute of Veterinary Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
Celine HeebInstitute of Veterinary Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0009-0007-3020-3780
Alexandra von Faber-CastellInstitute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
Jacqueline CondrauInstitute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
Ulrike Weber-StadlbauerInstitute of Veterinary Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-5278-9993
Matthias T WyssInstitute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-2037-3424
Aiman S SaabInstitute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-3886-8369
Sarah BeggiatoDepartment of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.
Urs MeyerInstitute of Veterinary Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-7244-0345
Bruno WeberInstitute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-9089-0689
Tina NotterInstitute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland. tina.notter@pharma.uzh.ch.

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 320030_232028Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) 407940_206399Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) P2ZHP3_174868
6 · The paper itself

Abstract

Astrocytes play critical roles in neural circuit function, but how they contribute to cognitive impairment remains poorly understood. Here, we identify astrocyte-derived kynurenic acid (KYNA), a neuroactive metabolite known to modulate multiple neurotransmitter receptor systems, including the N-methyl-D-aspartate receptor (NMDA), as a mediator of cognitive dysfunction in the context of aberrant astrocyte activity. Using chemogenetic stimulation, pharmacological rescue, and astrocyte-specific knockdown of kynurenine aminotransferase II (KAT II) in mice, we show that elevated KYNA suppresses parvalbumin-positive interneuron activity in the prefrontal cortex, leading to disinhibition of pyramidal neurons and impairments in cognitive functions linked to cortical activity, including episodic-like and working memory as well as sensorimotor gating. These findings define an astrocyte-KYNA-interneuron axis that controls cortical excitability and cognition, linking glial metabolism to circuit imbalance and cognitive dysfunction with potential relevance to psychiatric and neurological disorders.

Indexed as

AstrocytesCognitionKynurenic AcidPrefrontal CortexAnimalsInterneuronsMaleMemory, Short-TermMiceMice, Inbred C57BLParvalbuminsPyramidal CellsReceptors, N-Methyl-D-AspartateSensory GatingTransaminasesKynurenic Acidkynurenine-oxoglutarate transaminaseParvalbuminsReceptors, N-Methyl-D-AspartateTransaminases

Identifiers

PMID42098131
PMCPMC13369966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.